AG003HV6

60940-34-3 | EBSELEN

Chemical structure of EBSELEN, CAS 60940-34-3
AG003HV6
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 60940-34-3
Catalog Number AG003HV6(AGN-PC-09O84Y)
Chemical Name EBSELEN
IUPAC Name 2-phenyl-1,2-benzoselenazol-3-one
InChI InChI=1S/C13H9NOSe/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10/h1-9H
InChI Key DYEFUKCXAQOFHX-UHFFFAOYSA-N
MDL Number MFCD00210937
Molecular Formula C13H9NOSe
Molecular Weight 274.1767
SMILES O=C1N(C2=CC=CC=C2)[Se]C3=CC=CC=C13
UNII 40X2P7DPGH
Synonyms
2-phenyl-1,2-benzoisoselenazol-3(2H)-one, 2-phenylbenzoisoselenazol-3(2H)-one, DR 3305, DR-3305, ebselen, PZ 51, PZ-51, RP 60931, ebselen, 60940-34-3, 2-Phenyl-1,2-benzisoselenazol-3(2H)-one, 2-phenyl-1,2-benzoselenazol-3-one, Ebselene, Ebseleno, Ebselenum, Ebselene [French], Ebselenum [Latin], Ebselen [INN], Ebseleno [Spanish], SPI-1005, PZ 51, 2-phenylbenzo[d][1,2]selenazol-3(2H)-one, Harmokisane, PZ-51, C13H9NOSe, MLS000028488, UNII-40X2P7DPGH, CCRIS 3714, PZ51, DR-3305, 2-Phenyl-1,2-benzisoselenazolin-3-one, SMR000058445, 2-phenyl-1,2-benzoisoselenazol-3(2H)-one, 1,2-Benzisoselenazol-3(2H)-one, 2-phenyl-, CHEMBL51085, NSC 639762, DR 3305, Prestwick_1057, RP 60931, SPI-3005, AC1L1FDW, Prestwick0_000740, Prestwick1_000740, Prestwick2_000740, Prestwick3_000740, Spectrum2_001441, Spectrum3_000799, Spectrum4_000445, Spectrum5_001713, Lopac-E-3520, NSC639762, 40X2P7DPGH, Lopac0_000541, NCGC00015412-06, BSPBio_000700, BSPBio_001342, BSPBio_002538, CPD000058445, KBioGR_000062, KBioGR_000830, KBioSS_000062, DivK1c_000951, SPBio_001301, SPBio_002639, CAS-60940-34-3, MLS001148646, BPBio1_000770, BCBcMAP01_000149, CHEBI:77543, HMS502P13, KBio1_000951, KBio2_000062, KBio2_002630, KBio2_005198, KBio3_000123, KBio3_000124, KBio3_001758, NINDS_000951, DYEFUKCXAQOFHX-UHFFFAOYSA-N, E 3520, Bio2_000062, Bio2_000542, HMS1361D04, HMS1570C22, HMS1791D04, HMS1989D04, HMS2052N09, 2-Phenyl-benzo[d]isoselenazol-3-one, CCG-39161, MFCD00210937, AC-1124, IDI1_000951, IDI1_033812, QTL1_000035, NCGC00015412-01, NCGC00015412-02, NCGC00015412-03, NCGC00015412-13, NCGC00024072-03, NCGC00024072-04, NCGC00024072-05, NCGC00178610-01, NCGC00178610-02, NCGC00178610-03, 2-phenyl-1,2-benzoselenazol-3(2h)-one, AK115695, LS-33527, SAM001247071, AB00053217, EU-0100541, MLS-0003066.0001, BRD-K29359156-001-06-1, I09-1611, SR-01000003081, CID3194, Ebselen (C5), Ebselen, 99%, nchembio.109-comp1, Opera_ID_1643, Ebselen, cysteine modifier, cid_3194, DSSTox_CID_25150, DSSTox_RID_80704, C042986, DSSTox_GSID_45150, SCHEMBL33829, MLS001424261, MLS006010108, E3520_SIGMA, DTXSID7045150, BDBM34233, CTK7H1817, CHEBI:175507, HMS2097C22, HMS2235A11, HMS3394N09, HMS3402D04, HMS3649O05, HMS3714C22, KUC112559N, Pharmakon1600-01501188, BCP17134, EX-A1447, KS-00000G4G, Tox21_110140, BN0569, DAP001372, DR3305, GP4285, NSC757883, AKOS015898841, API0002512, CS-5534, DB12610, LP00541, NC00431, NSC-639762, NSC-757883, TRA0091838, KSC-325-014, NCGC00015412-04, NCGC00015412-05, NCGC00015412-07, NCGC00015412-08, NCGC00015412-09, NCGC00015412-10, NCGC00015412-11, NCGC00015412-12, phenyl-1,2-benzisoselenazol-3(2H)-one, 2-phenyl-1,2-benzisoselazol-3(2H)-one, AN-15216, BC224294, HY-13750, SBI-0050524.P003, 2-phenyl-1,2-benzisoselenazole-3(2H)-one, AB0020911, AX8127093, DB-072873, 2-phenyl-1,2-benzoisoselenazole-3(2H)-one, E0946, FT-0759332, V1941, 2-phenyl-1,2-benzoisoselenazole-3-(2H)-one, 2-Phenyl-benzo[d]isoselenazol-3-one(Ebselen), AB00053217_25, 940E343, SR-01000003081-2, SR-01000003081-7, SR-01000003081-8, BRD-K29359156-001-23-6, SR-01000003081-10, SR-01000003081-14, D0B1FE, Varespladib (LY315920), C13-H9-N-O-Se, 2-phenylbenzoisoselenazol-3(2H)-one, 2-(3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yloxy)acetic acid, 172732-68-2,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited